Background-End-stage heart failure is associated with impaired cardiac output (CO) and organ blood flow. We determined whether CO and peripheral perfusion are maintained during exercise in patients with an axial-flow left ventricular assist device (LVAD) and whether an increase in LVAD pump speed with work rate would increase organ blood flow. Methods and Results-Invasively determined CO and leg blood flow and Doppler-determined cerebral perfusion were measured during 2 incremental cycle exercise tests on the same day in 8 patients provided with a HeartMate II LVAD.
T he left ventricular assist device (LVAD) is superior to medical treatment for management of end-stage heart failure, 1 and patients with an LVAD have an actuarial survival rate of more than 70% at 18 months. 2 Although pulsatile and continuous-flow LVADs are comparable with respect to resting cardiac output (CO) and exercise capacity, [3] [4] [5] [6] axial-flow LVAD is preferred to the pulsatile LVAD because of its longer life span, lower incidence of stroke, and similar or better performance in terms of improvement in quality of life and functional capacity. 1, 2, 5 An LVAD is used as a bridge to recovery or transplantation 7 and increasingly as destination therapy, making it important how well the LVAD serves the demands of a physically active life.
Clinical Perspective on p 560
The pulsatile LVAD works in an automatic mode, with the pulsating rate responding to an increase in pump filling and by forwarding an increased venous return, thus providing for a substantial increase in CO during exercise. 4 In contrast, axial-flow LVAD usually works in a continuous mode with a fixed pump speed (Ϸ9000 to 10 000 rpm) set from determinations of the highest delivery of blood from the left ventricle (LV) when the patient is resting. The fixed pump speed is chosen as the speed that is high enough to ensure effective unloading of the LV yet low enough to avoid excessive emptying of the ventricle resulting in arterial hypotensive episodes ("suction"). 8 With a continuous (or axial) flow device, an increase in CO is seen with increasing venous return even if the pump speed is fixed, but modeling studies have suggested that pump outflow can be further increased with increasing pump speed (increased rotary frequency), 9, 10 and we therefore considered that it might be an advantage if the continuous-flow LVAD, like the pulsatile LVAD, increased pump speed during exercise. The initial increase in CO established after implantation of a fixed-speed LVAD supports a continuous improvement in exercise capacity and general reconditioning of the patient. 4 However, patients with an LVAD are still often working at the limits of their exercise capacity, 11 and even a small improvement in the ability to increase CO during exercise may be important because CO is the main determinant of maximal oxygen uptake in normal subjects. 12 Accordingly, we evaluated whether increased pump speed improves exercise capacity and if it elevates CO during exercise and improves perfusion of 2 important organs, that is, the exercising legs and the brain. 13, 14 In addition, we assessed if LVAD pump speed can be increased without causing episodes of arterial hypotension ("suction").
Methods
Eight patients with end-stage heart failure provided with a HeartMate II LVAD (Thoratec Corp, Pleasanton, CA), who had been clinically stable for more than 4 weeks before the study, participated in the trial. The patients provided informed consent as approved by the Ethics Committee of Copenhagen (07-041) in accordance with the Helsinki declaration. The patients were treated with angiotensinconverting enzyme inhibitors (6/8 patients), ␤-blockers (8/8 patients), spironolactone (8/8 patients), and warfarin (8/8 patients). The patients' INR, normally maintained between 2.0 and 3.0, was kept between 2.0 and 2.2 on the study day to minimize the risk of bleeding in response to the invasive procedures. Exclusion criteria included LVAD implantation less than 3 months before the study, 15 age Ͻ18 years, and significant comorbidities. The LVAD pump speed was adjusted using echocardiographic guidance no more than 4 weeks before the study, and the appropriateness of this setting was ensured on the test day by increasing and decreasing this pump speed by 1000 rpm. Increasing pump speed did not change the LV diameter, but lowering pump speed provided for an increase in the LV diameter.
Study Design
The patients performed 2 progressive maximal exercise tests on the same day, that is, one with a fixed pump speed and the other with the pump speed increased in parallel with the intensity of exercise. A paired randomization procedure resulted in 4 patients starting with exercise at constant pump speed, whereas the others started with exercise at increasing pump speed. Neither the patients nor the directly participating investigators were aware of the LVAD pump speed because it was set by a nurse who was not otherwise involved in the study. When increased, the increment of the pump speed was 400 rpm per exercise stage. This specific increase in pump speed was chosen on the basis of patient-specific sensitivity in LV dimensions to increments in LVAD pump speed at rest and on changes needed to increase CO in model studies. 9, 10, 15 The progressive exercise protocol included 30-W stages of 2 minutes on a modified semisupine cycling ergometer at a pedaling rate of 60 rpm as dictated by a metronome with the first stage chosen to be 60 W. Perceived exertion was rated from 6 (easy) to 20 (strenuous). 16 Before the first exercise protocol, patients were allowed a 30-minute semisupine rest, and the 2 maximal exercise protocols were separated by at least 60 minutes for the patients to recover from the initial exercise test and to allow venous lactate concentrations to return to the resting value.
Instrumentation and Measurements
After administration of local anesthesia (2% lidocaine) and, guided by ultrasound and pressure tracings, a 5F Swan-Ganz catheter (Baxter Healthcare Corp, Irvine, CA) was placed in the pulmonary artery through the right internal jugular vein. Central vascular pressures were referenced to atmospheric pressure through uni-flow pressure transducers (Baxter Healthcare Corp) zeroed below the sternal angle and connected to a pressure monitoring system (Dialogue-2000; IBC-Danica, Copenhagen, Denmark). At each stage, the CO was determined in triplicate, using boluses of icecooled 0.9% saline (Viridia CMS M1167/77A, Hewlett-Packard, Andover, MA). Three patients agreed to have right leg blood flow, primarily reflecting exercising skeletal muscle blood flow, determined. A catheter was inserted into the right femoral vein, and the tip of the catheter was advanced to a position 2 cm proximal to the inguinal ligament. A thermistor (Edslab, T.D. Probe, 94-030 -2.5F, Baxter A/S, Allerød, Denmark) was advanced 8 cm beyond the tip of the catheter, 17 and leg blood flow was measured by the constantinfusion thermodilution technique. 18 Briefly, venous and infusate temperatures were monitored before and during ice-cold saline infusion (10 to 15 seconds) at a rate of 120 mL ⅐ min Ϫ1 to establish a decrease in venous blood temperature of 0.6°to 2.0°C. Resting blood flow measurements were performed at an infusion rate of Ϸ30 mL ⅐ min Ϫ1 for 30 to 45 seconds. Infusate temperature (0°to 4°C) was measured at the site of entry of the catheter (Edslab flowthrough thermister). Venous blood temperature and saline infusate temperatures were recorded at a 400-Hz analog-to-digital sampling rate (Powerlab 16 s data acquisition system, Chart v4.13 software, AD Instruments, Sydney, Australia) onto the hard drive of a computer. Also, blood samples were obtained from both the femoral vein and the pulmonary artery during the last 30 seconds before transition to the next exercise level and immediately analyzed for oxygen content and lactate concentration (ABL-745, Radiometer Medical, Copenhagen, Denmark). Heart rate was determined by 3-lead ECG, and arterial oxygen saturation (SaO 2 ) was monitored by pulse oximetry. Echocardiographic interrogation of the LV was performed at rest and at the end of each exercise stage (IE33 Ultrasound machine, Philips, The Netherlands). LV dimensions were determined and fractional shortening calculated from end-systolic and end-diastolic 2D frames obtained in the parasternal long-axis window. We focused on mobility of the aortic valve and signs of suction (sudden reduction in LV size).
To determine cerebral perfusion, middle cerebral artery mean flow velocity (MCAV mean ) was followed beat-to-beat by transcranial Doppler through the temporal ultrasound window with a 2-MHz probe (Multidop X, DWL, Sipplingen, Germany; Figure 1 ). 19, 20 After obtaining the optimal signal-to-noise ratio, the probe position was secured with a headband and adhesive probe ultrasonic gel (Tensive, Parker Laboratories, Orange, NJ). MCAV mean reflects cerebral blood flow if the arterial diameter remains constant, and changes in MCA pulsation relative to V mean were assessed by the pulsatility index. 20 For healthy resting human subjects, MCAV mean is Ϸ51 cm ⅐ s Ϫ1 (range, 36 to 55 cm ⅐ s Ϫ1 ). 20 Cerebral tissue hemoglobin oxygen saturation of the frontal lobe (ScO 2 ) was determined by dual-wavelength near-infrared spectrophotometry with the sensor placed on the forehead above the frontal sinus (INVOS Cerebral Oximeter, Somanetics, Troy, MI). By spatial resolution, the INVOS spectrophotometer determines changes in the absorption of light at 808 and 750 nm and reports the ScO 2 with small or negligible influence from diploë and subcutaneous tissue. 21 The normal resting value is Ϸ75% (range, 59% to 91%), and a clinically significant decrease in cerebral perfusion is associated with a decrease in ScO 2 of 10% to 15%. [21] [22] [23] Another optode was placed over the left rectus femoris muscle for detection of the exercising skeletal muscle oxygen saturation (SmO 2 ; normal resting value Ϸ75; range, 70% to 87%). [21] [22] [23] 
Statistical Analysis
One-way ANOVA for repeated measures was used to evaluate changes between and within conditions. Changes from rest to light exercise (60 W, considered to correspond to everyday living) and from rest to maximal exercise were analyzed. Paired data were compared with the Holm-Sidak test if normally distributed and by Dunn test if this was not the case. Data are presented as meanϮSD or, if not normally distributed, as medians with ranges. A probability value of Ͻ0.05 was considered statistically significant. Prestudy values for changes in CO and exercise capacity for patients provided with a HeartMate device were not available and, accordingly, a calculation of statistical power was not performed.
Results
Baseline characteristics of the patients are presented in Table 1 . The resting pump speed was 9775 rpm (range, 9400 to 10 200 rpm). The pump speed remained unchanged at the resting value in one exercise bout, and the pump speed was increased stepwise to a maximum of 11 500 rpm (11 300 to 11 700 rpm; 17% [16% to 21%]) in the other exercise bout. No patient was pacemakerdependent for the increase in heart rate. With the fixed pump speed, the aortic valve was closed during the entire cardiac cycle in 6 patients, whereas 2 patients demonstrated intermittent opening of the valve without any detectable flow across the valve. No cases of LV suction, or any other potential adverse reactions, were noted during exercise, either with constant or with increasing pump speed. At the highest work load, patients expressed an exertion rate of 19. 19, 20 Five patients were exhausted after having completed 4 stages (150 W) and 3 patients after having completed 5 stages (180 W) without differences between exercise conditions. Exercise time was similar between conditions (698Ϯ270 seconds for the increased pump speed versus 700Ϯ300 seconds for the constant pump speed; Pϭ0.94).
Constant Pump Speed

Light Exercise (60 W)
At rest, the aortic valve was open in only 2 patients. The results documented normal flows and anaerobic metabolism (pH and lactate) during rest but a low cerebral perfusion, with an MCAV mean of 39Ϯ14 cm ⅐ s Ϫ1 (Ϸ80% of normal; Table 2 ). From rest to the first stage of exercise (60 W), the number of patients with aortic valve opening increased from 2 to 5, but we did not observe any changes in LV dimensions or fractional shortening (Table 2 ). Systemic hemodynamics, CO, MCAV mean , ScO 2 , central venous pressure, and LV diameters did not change from rest to 60 W ( Table 2) . Leg blood flow increased, whereas total central venous oxygen saturation and skeletal muscle saturation decreased (all PϽ0.05).
Maximal Exercise
During maximal exercise, the aortic valve opened in 7 patients, but LV dimensions and fractional shortening were unchanged ( Table 2) . From rest to maximal exercise, CO, heart rate, mean (all PϽ0.001) and systolic pulmonary artery pressures (PϽ0.01) increased ( Figure 2 and Table 2) , whereas diastolic pulmonary artery pressure was unchanged. SaO 2 remained unchanged, whereas venous pH decreased to 7.21 (7.17 to 7.24) and venous lactate increased to 
Increasing Pump Speed
Light Exercise (60 W)
At 60 W, CO reached a higher value with increasing pump speed compared with constant pump speed (8.7Ϯ0.6 versus 8.1Ϯ1.1 L ⅐ min Ϫ1 ; Pϭ0.051; Figure 2 ), and the MCAV mean increased by 5.2Ϯ2.8 cm ⅐ s Ϫ1 (13% increase from rest; PϽ0.001 versus rest and constant pump speed). Compared with rest, ScO 2 was reduced but by less than what is considered clinically meaningful. Changes to all other variables were similar to those seen during exercise with constant pump speed.
Maximal Exercise
With increasing pump speed, MCAV mean decreased to the resting value, but MCAV mean was still significantly higher than the value attained with the fixed pump speed ( Table 2) . Compared with rest, ScO 2 was reduced but by less than what is considered clinically meaningful. Changes in all other variables were similar to those for the exercise condition with constant pump speed.
Discussion
This study examined CO and leg and cerebral perfusion in patients with systolic heart failure supported by an axial-flow LVAD before and during strenuous dynamic exercise and evaluated if increments in LVAD pump speed corresponding to the increase in exercise level might influence these blood flows. Even if the LVAD pump speed was constant at the level set at rest, CO and leg blood flow increased significantly during strenuous cycling exercise. Cerebral perfusion, however, was only Ϸ80% of the perfusion observed in normal subjects at rest, and it did not increase with exercise. A moderate increase in LVAD pump speed during exercise was well tolerated by the patients but did not improve exercise tolerance. The increase in pump speed, however, was associated with an elevated CO during light exercise, and perhaps more importantly with an improved cerebral perfusion: thus, the otherwise low cerebral perfusion now increased to a small extent with exercise. An LVAD relieves the LV by continuously forwarding blood from the LV apex to the aorta, repositioning the otherwise up-and right-shifted LV pressure-volume loop toward normal values (ie, a left and downward shift). We thus expected the increasing pump speed to shift the LV pressurevolume loop further down and leftward. 24 Flow and pressure across the LVAD covary with pump speed along with influences from blood volume, blood viscosity, baroreflex adjustments, and LV contractility. In an axial-flow LVAD, pump flow (and if the aortic valve remains closed also the CO) is nonlinearly related to pump speed. 24, 25 Model data 10 suggest that an increment of 400 rpm above the pump speed already unloading the LV results in a Ϸ400 mL ⅐ min Ϫ1 increase in transpump blood flow and hence CO. In line with these predictions, we did observe a Ϸ400 mL ⅐ min Ϫ1 increase in CO from rest to the first stage of exercise with a 400-rpm increment in pump speed, and it is likely that further increments in pump speed would increase CO to a greater extent. If further improvements are to be seen with exerciserelated increments in LVAD pump speed, it is important to first demonstrate that moderate increments are possible without the risk of inadequate filling of the LV and arterial hypotension. With the chosen increments in pump speed, we did not observe any episodes of suction, and the echocardi- ography evaluation did not demonstrate any lowering in LV diameter. Accordingly, we consider that pump speed could be safely increased further.
The LVAD achieved significant increments in CO during exercise, even with the constant pump speed. Thus, with strenuous exercise and a fixed pump speed, CO increased by 9.0 L ⅐ min Ϫ1 (precisely corresponding to the increase in leg blood flow), and the 17% augmentation in LVAD pump speed did not provide any further increment in maximal CO or a further reduction in anaerobic metabolism (as shown by unchanged plasma pH and lactate levels). The increase in CO (to 8.1 and 13.6 L ⅐ min Ϫ1 at 90 and 150 W, respectively) remains far below what is seen in normal subjects (Ϸ19 L ⅐ min Ϫ1 at 145 W with a similar protocol), 26 but the changes in CO and lactate are not far from what is seen in patients with heart failure with relatively better LV systolic function (LV ejection fraction, 0.40; New York Heart Association class I-II; Ϸ11 L ⅐ min Ϫ1 at 90 W). 27 We hypothesized that CO would increase to a greater extent with higher pump speed but were unable to demonstrate such an elevation, possibly because CO had already been significantly increased by insertion of the HeartMate and because we routinely set a high resting pump speed (9400 to 10 200 rpm versus 8600 to 9800 rpm reported in other patients 8 ) . Unchanged LV diameters during exercise suggest that pump speed can be increased further, and we speculate that further increments in pump speed would translate into more pronounced elevations in CO compared with what was observed in our patients at 60 W. With augmented CO and cerebral perfusion, we speculated that exercise tolerance would improve, but it did not. This demonstrates that the ability to improve cerebral perfusion is only one determinant of what limits exercise performance in patients with severe heart failure, who have already improved their exercise capacity considerably by having a LVAD inserted, and who are now capable of carrying out quite strenuous exercise. In healthy individuals, cardiopulmonary function plays an important role in exercise performance, whereas in patients with chronic heart failure, the relationship is less clear. 28, 29 We used transcranial Doppler with insonation of the MCA to determine cerebral perfusion. Transcranial Doppler is a well-validated measure of cerebral perfusion in normal subjects and patients with heart failure, 19, 28, 29 and the increase in pulsatile flow velocity with exercise intensity indicates that cerebral perfusion by transcranial Doppler is a valid measure of cerebral blood flow also in LVAD patients. In normal subjects, MCAV mean increases from Ϸ50 to 65 cm ⅐ s Ϫ1 , 20, 30 and ScO 2 also tends to increase 31 during dynamic exercise. In our patients, the LVAD secured a normal resting CO that allowed for a near-normal exercise tolerance, 6 but cerebral perfusion was low even at rest, and it was negatively impacted by exercise when the LVAD pump speed was kept constant. On the other hand, cerebral perfusion was increased during light exercise, and although cerebral perfusion did not increase to levels reached in normal subjects at maximal exercise level, cerebral perfusion remained elevated with increasing pump speed.
The increase in cerebral perfusion with increasing pump speed is probably related to a small increment in CO perhaps in combination with an increase in arterial blood pressure. At rest, cerebral perfusion is autoregulated and influenced mainly by the arterial carbon dioxide tension, but, during exercise, cerebral perfusion is also related to CO, 32 as demonstrated in normal subjects in response to ␤ 1 -blockade and in patients with heart failure or atrial fibrillation. [33] [34] [35] Because the change in leg blood flow accounted for most if not all of the increase in CO, the improvement in cerebral perfusion induced by an augmentation of pump speed represents not only a redistribution of an elevated CO but perhaps also an elevation in arterial pressure. Simulation data 14 suggest that in our patients, an increase in pump speed is associated with an increase in mean arterial pressure of Ϸ5 mm Hg. It is likely that further increments in LVAD pump speed will increase CO and arterial pressure to the extent that cerebral perfusion can reach normal values and cerebral tissue oxygenation will increase, as is the case in normal subjects.
New generations of LVADs have focused on becoming mechanically simpler with transcutaneous delivery of energy, but this study supports also maintaining interest in improving automaticity of LVADs. To conform to the Frank-Starling law of the heart, pump speed should be increased in parallel with LV volume or filling pressure. Although impressive values for resting and exercise-induced increments in CO and leg blood flow were seen with a constant LVAD pump speed, cerebral perfusion was low in comparison with what is seen in normal subjects. Although, we applied slightly higher pump speeds than the often reported 8600 to 9800 rpm, 8 cerebral perfusion did not increase in response to exercise if the pump speed was kept constant. However, a further 17% increase in LVAD pump speed with exercise provided for an increase and hence a partial normalization of an otherwise poor cerebral perfusion.
